Sphingosine kinase-1 is a downstream regulator of imatinib-induced apoptosis in chronic myeloid leukemia cells

Leukemia
E BonhoureO Cuvillier

Abstract

We examined the involvement of sphingosine kinase-1 (SphK1), which governs the ceramide/sphingosine-1-phosphate balance, in susceptibility to imatinib of either sensitive or resistant chronic myeloid leukemia cells. Imatinib-sensitive LAMA84-s displayed marked SphK1 inhibition coupled with increased content of ceramide and decreased pro-survival sphingosine-1-phosphate. Conversely, no changes in the sphingolipid metabolism were observed in LAMA84-r treated with imatinib. Overcoming imatinib resistance in LAMA84-r with farnesyltransferase or MEK/ERK inhibitors as well as with cytosine arabinoside led to SphK1 inhibition. Overexpression of SphK1 in LAMA84-s cells impaired apoptosis and inhibited the effects of imatinib on caspase-3 activation, cytochrome c and Smac release from mitochondria through modulation of Bim, Bcl-xL and Mcl-1 expression. Pharmacological inhibition of SphK1 with F-12509a or its silencing by siRNA induced apoptosis of both imatinib-sensitive and -resistant cells, suggesting that SphK1 inhibition was critical for apoptosis signaling. We also show that imatinib-sensitive and -resistant primary cells from chronic myeloid leukemia patients can be successfully killed in vitro by the F-12509a inhibitor. These res...Continue Reading

References

Apr 5, 2000·The Journal of Biological Chemistry·O CuvillierS Spiegel
Dec 15, 2000·Current Biology : CB·P XiaM A Vadas
Mar 10, 2001·Journal of Neurochemistry·L C EdsallS Milstien
Oct 5, 2001·Expert Opinion on Pharmacotherapy·A ReiterR Hehlmann
Jul 10, 2003·Blood Cells, Molecules & Diseases·Kiyotaka KawauchiShin ichiro Ohkawa
Oct 9, 2003·The EMBO Journal·Stuart M PitsonBinks W Wattenberg
Feb 3, 2004·Journal of Cellular Physiology·Kanoko KohmuraMasahiro Kizaki
Feb 28, 2004·The Journal of Biological Chemistry·Tarek A TahaLina M Obeid
Dec 17, 2005·Cancer Research·Dimitri PchejetskiOlivier Cuvillier
Jun 16, 2006·The New England Journal of Medicine·Moshe TalpazCharles L Sawyers
Jun 16, 2006·The New England Journal of Medicine·Hagop KantarjianOliver G Ottmann
Sep 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·Junya KurodaAndreas Strasser
Sep 28, 2006·Proceedings of the National Academy of Sciences of the United States of America·Scott H Kaufmann
May 25, 2007·Nature Reviews. Cancer·Junia V Melo, David J Barnes

❮ Previous
Next ❯

Citations

Oct 18, 2011·Cancer Metastasis Reviews·Jessie W YesterTomasz Kordula
Jun 18, 2010·Nature Reviews. Cancer·Nigel J Pyne, Susan Pyne
Nov 20, 2012·Journal of Lipid Research·Tara Ann BurnsChiara Luberto
Jun 11, 2009·Journal of Lipid Research·Nicole O'BrienRoger Sabbadini
Nov 7, 2008·Journal of Lipid Research·Michael MaceykaSarah Spiegel
Apr 8, 2014·European Journal of Medicinal Chemistry·Esther CarrascoFernando Rodríguez-Serrano
Feb 9, 2011·Leukemia & Lymphoma·Amanda J RedigLeonidas C Platanias
Jul 16, 2008·Expert Opinion on Therapeutic Targets·Olivier Cuvillier
May 23, 2012·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·James R Van Brocklyn, Joseph B Williams
Jul 28, 2011·Advances in Biological Regulation·Nigel J PyneSusan Pyne
Oct 26, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Bernard MalavaudOlivier Cuvillier
Feb 16, 2010·Biochemical and Biophysical Research Communications·Xiao-Yun LiuLi-Sheng Wang
Nov 28, 2008·British Journal of Haematology·Clara RicciRiccardo Ghidoni
Mar 23, 2013·British Journal of Pharmacology·A SinclairT L Holyoake
May 27, 2010·International Journal of Cancer. Journal International Du Cancer·Huseyin Atakan Ekiz, Yusuf Baran
Mar 26, 2013·British Journal of Haematology·Craig T Wallington-BeddoeLinda J Bendall
Jun 13, 2009·International Journal of Cancer. Journal International Du Cancer·Lysann SauerDmitry Pchejetski
Apr 15, 2011·Journal of Lipids·Wei-Ching HuangChiou-Feng Lin
Mar 18, 2015·Biochemical and Biophysical Research Communications·Wenhua LiZhihua Ruan
Mar 26, 2013·Biochimica Et Biophysica Acta·Tejia Zhang, Alan Saghatelian
Aug 3, 2016·Medicinal Research Reviews·Dominik Vogt, Holger Stark
Jun 18, 2017·Science China. Life Sciences·Zuoquan XieMeiyu Geng
Jan 24, 2018·British Journal of Haematology·Craig T Wallington-BeddoeLinda J Bendall
Apr 2, 2016·Oncotarget·Christopher WhiteDmitri Pchejetski
Jun 5, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Leyre BrizuelaOlivier Cuvillier
Mar 7, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Katarzyna Bocheńska, Magdalena Gabig-Cimińska

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis